Alerts will be sent to your verified email
Verify EmailWOCKPHARMA
Wockhardt
|
JB Chem & Pharma
|
Eris Lifesciences
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Domestic Sales Growth - YoY
|
10.6 % | 10.1 % | 6.1 % |
R&D as a % of Total Sales
|
4.6 % | 1.35 % | 0.0 |
Financials
|
|||
5 yr Average ROE
|
-3.51 % | 19.49 % | 17.74 % |
5yr average Equity Multiplier
|
2.02 | 1.52 | 1.76 |
5yr Average Asset Turnover Ratio
|
0.39 | 0.77 | 0.51 |
5yr Avg Net Profit Margin
|
-4.28 % | 16.71 % | 22.76 % |
Price to Book
|
6.22 | 8.05 | 8.6 |
P/E
|
0.0 | 40.35 | 69.76 |
5yr Avg Cash Conversion Cycle
|
-94.15 Days | 7.58 Days | -54.68 Days |
Inventory Days
|
61.29 Days | 50.33 Days | 27.48 Days |
Days Receivable
|
60.36 Days | 67.54 Days | 54.07 Days |
Days Payable
|
251.45 Days | 90.39 Days | 148.48 Days |
5yr Average Interest Coverage Ratio
|
-0.43 | 58.81 | 66.44 |
5yr Avg ROCE
|
-0.28 % | 23.05 % | 18.34 % |
5yr Avg Operating Profit Margin
|
5.03 % | 24.73 % | 34.43 % |
5 yr average Debt to Equity
|
0.56 | 0.07 | 0.46 |
5yr CAGR Net Profit
|
n/a | 8.05 % | -0.19 % |
5yr Average Return on Assets
|
-1.79 % | 12.98 % | 12.4 % |
Shareholdings
|
|||
Promoter Holding
|
49.09 % | 47.73 % | 54.83 % |
Share Pledged by Promoters
|
15.64 % | 0.0 | 16.93 % |
Change in Promoter Holding (3 Yrs)
|
-16.66 % | -6.27 % | 2.53 % |
Change in Mutual Fund Holding (3 Yrs)
|
7.99 % | 1.15 % | 6.42 % |
Wockhardt
|
JB Chem & Pharma
|
Eris Lifesciences
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|